Nuvei Corporation NVEI
33.99 USD 0.00 (+0.00%)
At closeNov 15, 2024, 4:00 PM EST
33.99 Day range 33.99
31.83 52-week range 34.00
- YTD
- 0.00%
- 1 year
- 0.00%
Analyst view
Price target (mean) —
Ratings (0m) 6 0 buy · 6 hold · 0 sell
- Strong buy0
- Buy0
- Hold6
- Sell0
- Strong sell0
Recommendation trend
- This month 6
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.50 | 0.47 – 0.53 | 0.39 | +28.2% | 338.00M | +10.9% | 5 |
| Current quarter | 0.46 | 0.43 – 0.48 | 0.39 | +17.9% | 330.17M | +7.5% | 7 |
| Current quarter | 0.43 | 0.34 – 0.50 | 0.44 | -2.3% | 325.48M | +26.9% | 13 |
| Current quarter | 0.40 | 0.37 – 0.43 | 0.43 | -7.0% | 304.85M | +54.6% | 13 |
| Current quarter | 0.45 | 0.41 – 0.50 | 0.51 | -11.8% | 305.87M | +44.8% | 12 |
| Current quarter | 0.44 | 0.38 – 0.48 | 0.46 | -4.3% | 256.50M | +19.6% | 7 |
| Current quarter | 0.38 | 0.35 – 0.42 | 0.42 | -9.5% | 197.15M | +7.2% | 6 |
| Current quarter | 0.45 | 0.43 – 0.47 | 0.00 | 0.0% | 219.16M | 0.0% | 6 |
| Current quarter | 0.41 | 0.39 – 0.45 | 0.00 | 0.0% | 214.54M | 0.0% | 6 |
| Current quarter | 0.36 | 0.36 – 0.36 | 0.00 | 0.0% | 178.20M | 0.0% | 1 |
| Next quarter | 0.5383 | 0.4748 – 0.58 | 0.41 | +31.3% | 391.70M | +16.9% | 3 |
| Current year | 1.90 | 1.79 – 1.97 | 1.69 | +12.7% | 1.37B | +15.4% | 7 |
| Current year | 1.68 | 1.60 – 1.81 | 1.86 | -9.7% | 1.19B | +40.9% | 16 |
| Current year | 1.86 | 1.81 – 1.92 | 1.69 | +10.1% | 844.12M | +16.5% | 6 |
| Current year | 1.66 | 1.58 – 1.70 | 0.00 | 0.0% | 724.53M | 0.0% | 7 |
| Next year | 2.52 | 2.41 – 2.63 | 1.90 | +32.2% | 1.60B | +16.5% | 8 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| May 8, 2024 | JP Morgan | Downgrade | Overweight | Neutral |
| Apr 3, 2024 | Citigroup | Maintained | Neutral | Neutral |
| Apr 3, 2024 | UBS | Downgrade | Buy | Neutral |
| Apr 3, 2024 | Canaccord Genuity | Downgrade | Buy | Hold |
| Apr 2, 2024 | Scotiabank | Downgrade | Sector Outperform | Sector Perform |
| Apr 2, 2024 | Canaccord Genuity | Maintained | Buy | Buy |
| Apr 2, 2024 | Seaport Global | Downgrade | Buy | Neutral |
| Apr 2, 2024 | Keefe, Bruyette & Woods | Downgrade | Outperform | Market Perform |
| Apr 2, 2024 | Wolfe Research | Downgrade | Outperform | Peer Perform |
| Mar 11, 2024 | Barclays | Maintained | Overweight | Overweight |
| Mar 7, 2024 | Seaport Global | Maintained | Buy | Buy |
| Mar 7, 2024 | UBS | Maintained | Buy | Buy |
| Mar 7, 2024 | Wells Fargo | Maintained | Equal-Weight | Equal-Weight |
| Mar 7, 2024 | RBC Capital | Maintained | Outperform | Outperform |
| Mar 7, 2024 | Canaccord Genuity | Reiterated | Buy | Buy |
| Jul 8, 2021 | Canaccord Genuity | Initiated | — | Buy |